预防性输尿管支架置入预防胎盘植入谱系疾病子宫切除术中泌尿生殖道损伤:系统评价与Meta分析
该系统评价与Meta分析纳入9项研究共848例产前疑似胎盘植入谱系疾病行剖宫产子宫切除术的患者,比较预防性输尿管支架置入与否的泌尿生殖道损伤率。支架组与非支架组泌尿生殖道损伤率无显著差异(RR 0.94,95%CI 0.74-1.20),支架组失血量平均减少392 mL(95%CI 52.74-738.13),输血量无差异。
要点
- 预防性输尿管支架未显著降低剖宫产子宫切除术中泌尿生殖道损伤率(RR 0.94,95%CI 0.74-1.20)。
- 支架组失血量平均减少392 mL(95%CI 52.74-738.13),输血量无差异。
- 产前疑似胎盘植入谱系疾病行剖宫产子宫切除术时,预防性支架置入对泌尿生殖道损伤无保护作用。
核心结论
- 预防性输尿管支架置入未降低产前疑似胎盘植入谱系疾病行剖宫产子宫切除术患者的泌尿生殖道损伤率。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Cochrane Library和ClinicalTrials.gov从建库至2022年2月至2022年12月,纳入9项研究共848例患者。
- 523例(61.7%)置入预防性输尿管支架,325例(38.3%)未置入。
- 方案已在International Prospective Register of Systematic Reviews注册(注册号CRD42022372817),采用Newcastle-Ottawa量表评估质量与偏倚风险。
主要发现
- 泌尿生殖道损伤在支架组138/523例(26.4%)vs 非支架组83/325例(25.5%),RR 0.94(95%CI 0.74-1.20)。
- 两组输注浓缩红细胞平均数量无差异。
- 支架组失血量平均减少392 mL(95%CI 52.74-738.13)。
关键数值与推荐
- 泌尿生殖道损伤定义为膀胱切开、输尿管损伤和/或膀胱瘘,包括有意和无意损伤。
- 纳入标准为产前疑似胎盘植入谱系疾病行剖宫产子宫切除术、比较支架置入与否的泌尿生殖道损伤率的研究。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to assess the effectiveness of prophylactic ureteral stent placement for the prevention of genitourinary tract injury at the time of cesarean hysterectomy for placenta accreta spectrum. The secondary objectives were to assess mean blood loss, operative time, number of packed red blood cells transfused, and rates of urinary tract infection among patients undergoing cesarean hysterectomy for placenta accreta spectrum with and without prophylactic ureteral stent placement. DATA SOURCES: The search was performed using PubMed, Cochrane Library, and ClinicalTrials.gov from inception to February 2022 to December 2022. The protocol for this review was registered with the International Prospective Register of Systematic Reviews before data collection (registration number: CRD42022372817). STUDY ELIGIBILITY CRITERIA: All studies that examined differences in the rate of genitourinary tract injury among women undergoing cesarean hysterectomy for prenatally suspected placenta accreta spectrum with and without placement of prophylactic ureteral stents were included. Genitourinary injury was defined as cystotomy, ureteral injury, and/or bladder fistula. Cases of both intentional and unintentional genitourinary injuries were included in the analysis. METHODS: For all studies meeting the inclusion criteria, the following data were extracted: number of included patients, maternal demographic information, obstetrical history, type of invasive placentation, placement of stents (yes or no), type of stent placed, blood loss, operative time, genitourinary tract injury, and urinary tract infection. Pooled data analysis was completed using the Review Manager (version 5.3; Nordic Cochrane Centre, Copenhagen, Denmark; Cochrane Collaboration, 2014). The summary measures were reported as summary relative risk or as summary mean difference. The quality and risk of biases of the included studies were assessed according to the Newcastle-Ottawa Scale. RESULTS: Overall, 9 studies, including 848 patients, fulfilled our inclusion criteria and were included in our analysis. Moreover, 523 patients (61.7%) had prophylactic ureteral stents placed, and 325 patients (38.3%) did not. Genitourinary injury occurred in 138 of 523 patients (26.4%) in the ureteral stent group vs 83 of 325 patients (25.5%) in the no ureteral stent group (relative risk, 0.94; 95% confidence interval, 0.74-1.20). The mean number of packed red blood cells transfused did not differ between the 2 groups. The pooled analysis demonstrated decreased blood loss among patients who received prophylactic ureteral stents, with a mean difference of 392 mL (95% confidence interval, 52.74-738.13). CONCLUSION: Our systematic review and meta-analysis demonstrated no difference in the rates of genitourinary tract injury with the use of prophylactic ureteral stent placement among cases of prenatally suspected placenta accreta spectrum undergoing cesarean hysterectomy.
引用
- Horgan R, Hessami K, Hage Diab Y, et al. Prophylactic ureteral stent placement for the prevention of genitourinary tract injury during hysterectomy for placenta accreta spectrum: systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 37549736. doi:10.1016/j.ajogmf.2023.101120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。